Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Abeona Therapeutics Activates Second Clinical Trial Site In EB-101 Pivotal Phase 3 VIITAL Study For Recessive Dystrophic Epidermolysis Bullosa


Benzinga | Jul 23, 2021 07:36AM EDT

Abeona Therapeutics Activates Second Clinical Trial Site In EB-101 Pivotal Phase 3 VIITAL Study For Recessive Dystrophic Epidermolysis Bullosa






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC